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Abstract 
Background: Wallerian degeneration (WD) in injured peripheral nerves is associated with a large number of up- or 
down-regulated genes, but the effects of these changes are poorly understood. In our previous studies, we reported 
some key factors that are differentially expressed to activate nerve degeneration and regeneration during WD. Here, 
we determined the effects of secreted phosphoprotein 1 (Spp1) on WD after rat sciatic nerve injury.
Results: Spp1 was upregulated from 6 h to 14 days after sciatic nerve injury. Altered expression of Spp1 in Schwann 
cells (SC) resulted in altered mRNA and protein expression levels for cytokines, c-Fos, PKCα and phospho-ERK/ERK and 
affected SC apoptosis in vitro. Silencing of Spp1 expression in SCs using siRNA technology reduced proliferation and 
promoted migration of SCs in vitro. By contrast, overexpression of Spp1 promoted proliferation and reduced migra-
tion in SCs in vitro. Differential expression of Spp1 after sciatic nerve injury in vivo altered the expression of cytokines, 
c-Fos, PKCα, and the p-ERK/ERK pathway.
Conclusions: Spp1 is a key regulatory factor that affects nerve degeneration and regeneration through c-Fos, PKCα 
and p-ERK/ERK pathways after rat sciatic nerve injury. These results shed new light on the role of Spp1 in nerve degen-
eration and regeneration during WD.
Keywords: Wallerian degeneration, Secreted phosphoprotein 1 (Spp1), Schwann cells, Nerve regeneration, Rat, 
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Background
Wallerian degeneration (WD), the degeneration of the 
axon distal to a site of transaction, occurs in both axons 
and myelin after injury to the peripheral nervous sys-
tem (PNS) [1–3]. The PNS, unlike the central nervous 
system (CNS), is capable of regeneration after an injury 
that causes WD processes to begin [4, 5]. A number of 
studies have found that nerve injury not only plays a key 
role in modulating the activities of Schwann cells but also 
promotes axonal regeneration by releasing a large num-
ber of regeneration-related factors, including cytokines, 
growth factors, and chemokines [5–7]. Therefore, it is 
important to elucidate the key factors involved in regu-
lating the degeneration and regeneration that occurs in 
the PNS after injury [8–11]. The molecular mechanisms 
regulating WD are not yet completely understood, but 
understanding the factors that regulate rapid responses 
during WD may reveal the mechanisms underpinning 
nerve repair and regeneration [12–16].
Secreted phosphoprotein 1 (Spp1) belongs to the family 
of secreted acidic proteins. It has a large number of con-
sensus sequence sites and multiple phosphorylation sites 
and binds to several integrin receptors, which have been 
well established to function in cell adhesion, migration, 
and survival [17]. Spp1 is expressed in a range of immune 
cells and reported to act as an immune modulator, which 
promotes cell recruitment to inflammatory sites [17]. 
It also functions as an adhesion protein involved in cell 
attachment and wound healing [17, 18]. Stimulation of 
Spp1 expression leads to an increase in cell pro-inflam-
matory cytokine levels, although the regulatory pathways 
are not yet known [17–19].
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We previously reported on gene expression signal flow 
and pathways regulated by key factors as determined 
by microarray analyses, such as claudins, transforming 
growth factor beta 1, Spp1, and toll-like receptor 4, dur-
ing the processes of WD after rat sciatic nerve injury [11–
15]. Here, we examined the effect of Spp1 on cytokine 
release, cell apoptosis, cell migration and proliferation, 
and signaling pathways in vitro and in vivo.
Methods
Animal model
Male Sprague–Dawley rats (180–200 g) were provided by 
the Experimental Animal Center of Nantong University. 
The rats were randomly divided into eight groups (six 
rats per group) and underwent sciatic neurectomy. All 
animal tests were conducted in accordance with the US 
National Institutes of Health’s Guide for the Care and Use 
of Laboratory Animals and by the Key Laboratory of Neu-
roregeneration Guidelines for the Care and Use of Labo-
ratory Animals. The Institutional Animal Care and Use 
Committee of Nantong University approved all protocols 
used in this study.
The rats were anesthetized using an injection of com-
plex narcotics (85  mg/kg trichloroacetaldehyde mono-
hydrate, 42  mg/kg magnesium sulfate, and 17  mg/kg 
sodium pentobarbital), and the sciatic nerve was identi-
fied and lifted through an incision on the lateral aspect 
of the mid-thigh of the right hind limb. The sciatic nerve 
was cut, and a 1-cm segment was excised. One group of 
rats was immediately used in experiments (0 h), and the 
other groups were used 6, 12, and 24 h as well as 1, 2, 3, 
and 4 weeks after the surgery. The 0-h animals received 
sham operations.
Primary culture of Schwann cells
The rats for this experiment were provided by the Experi-
mental Animal Center of Nantong University. The rats 
were sacrificed, and Schwann cells (SCs) were isolated 
from the sciatic nerves. The SCs were treated with anti-
Thy1.1 antibody (Sigma, St Louis, MO) and rabbit com-
plement (Invitrogen, Carlsbad, CA) to remove fibroblasts 
as previously described [20]. SCs were cultured from the 
sciatic nerves of 1-day-old Sprague–Dawley rats as previ-
ously described [20]. Primary cultures of Schwann cells 
were maintained in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% fetal bovine serum at 
37 °C in a humidified 5% CO2 atmosphere.
Spp1 siRNA transfection of Schwann cells
Three different small interfering RNAs (siRNAs) 
(Table  1) were used to perform RNA interference. SCs 
were transfected with Spp1 siRNAs (Integrated Bio-
tech Solutions, Shanghai, China) using Lipofectamine 
RNAi MAX transfection reagent (Invitrogen, Carlsbad, 
CA, USA) according to the manufacturer’s instructions. 
Black control that raised normally and NC-siRNA were 
tested. The siRNA-1, 2, 3 transfection experiments were 
repeated three times.
Overexpression of Spp1 in Schwann cells
SCs were cultured in DMEM (GIBCO, Grand Island, 
NY) with 100  IU/mL penicillin, 10% fetal calf serum, 
and 100  g/mL streptomycin at 37  °C and 5% CO2. The 
SCs were identified by examining the immunofluores-
cence of an antibody to the marker S100, and the final 
cells were found to comprise 98% SCs. The Spp1 over-
expression plasmid pcDNA3.1-Spp1 was constructed as 
previously described [21]. A mixture of pcDNA3.1-Spp1 
plasmid and X-treme GENE HP DNA Transfection Rea-
gent (Roche, Mannheim, Germany), or X-treme GENE 
HP DNA Transfection Reagent and an empty vector were 
then transfected into SCs for 48 h. After that, real-time 
quantitative (q)PCR and Western blot analyses were con-
ducted. The pcDNA3.1-Spp1 overexpression experiments 
were repeated three times.
Real‑time quantitative PCR analysis
Total RNA was extracted with Trizol regent, and cDNA 
was synthesized with a cDNA Reverse Transcription Kit 
(Qiagen, Valencia, CA, USA). Real-time qPCR was per-
formed using a 7300 Real-Time PCR System according to 
the manufacturer’s protocols. The analysis was repeated 
three times, and the reactions were conducted in tripli-
cate. The comparative Ct method was used to analyze the 
cycle threshold (Ct) values. The data were analyzed, and 
group differences were considered statistically significant 
at values of p less than 0.05.
Western blot analysis
Injured nerve samples and SCs were homogenized in pro-
tein lysis buffer containing protease inhibitors. The protein 
expression levels were analyzed using antibodies against 
anti-Spp1, AKT, phosphorylated (p)-AKT, protein kinase 
C-alpha (PKCα), c-Fos, extracellular signal-regulated kinase 
Table 1 Spp1 siRNA primers
Gene Sequence
NC F: 5′ UUCUCCGAACGUGUCACGUTT 3′
R: 5′ ACGUGACACGUUCGGAGAATT 3′
Spp1-1 F: 5′ CUAGAUGUCGGUGUCCCUUGC 3′
R: 5′ UGAAUGUUGCUGCGCAUCAUG 3′
Spp1-2 F: 5′ CGAUCGAUAGUGCCGAGAAGC 3′
R: 5′ UUCUCGGCACUAUCGAUCGCA 3′
Spp1-3 F: 5′ AGCUAGUCCUAGACCCUAAGA 3′
R: 5′ UUAGGGUCUAGGACUAGCUUG 3′
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(ERK), and p-ERK. The Western blot images were scanned 
with a GS800 Densitometer Scanner (Bio-Rad, Hercules, 
CA, USA), and the optical density data were analyzed using 
PDQuest 7.2.0 software. GAPDH was used as a reference 
to normalize the levels of protein. The data were analyzed, 
and group differences were considered statistically signifi-
cant at values of p less than 0.05. All injured nerve samples 
were analyzed in three independent experiments.
Flow cytometry analysis
The extent of SC apoptosis was measured using an 
Annexin V-FITC Apoptosis detection kit (Beyotime Insti-
tute of Biotechnology, China) as described by the manu-
facturer’s instructions. SCs were washed with PBS and 
then collected for flow cytometry analysis. FITC-labeled 
annexin V (5 μL) in binding buffer (195 μL) was incubated 
for 10 min at room temperature. The incubation was con-
tinued with 10 μL of propidium iodide for 10 min on ice 
in the dark. After that, the apoptotic cells were measured 
by FACScan flow cytometry.
Cell proliferation assay
Cultured SCs were plated at a density of 2 × 105 cells/mL 
onto 0.01% poly-l-lysine-coated plates. Cell proliferation 
was assayed at 2 days after cell transfection. EdU (50 µM) 
was added to the cell culture and incubated for 2  h. The 
SCs were then fixed with 4% formaldehyde for 30  min. 
After SC labeling, a Cell-Light EdU DNA Cell Proliferation 
Kit (Ribobio, China) was used to analyze cell proliferation 
according to the manufacturer’s protocol. Cell prolifera-
tion was expressed as the ratio of EdU-positive cells, which 
was defined by images of randomly selected fields obtained 
Fig. 1 Spp1 expression in injured rat sciatic nerve and cultured Schwann cells. a Real-time qPCR analysis of Spp1 expression in injured sciatic 
nerves 0, 6, 12, and 24 h as well as 1 and 2 weeks post injury. GAPDH was used to normalize the data. The average of three independent experi-
ments is shown as mean ± SEM (*p < 0.05). b Western blot analysis of Spp1 expression levels in injured sciatic nerves 0, 6, 12, and 24 h as well as 1 
and 2 weeks post injury. GAPDH levels were used as a control. c Relative protein expression levels of Spp1 in Western blot analyses. d Immunofluo-
rescence staining of S100 and Spp1 (and their overlay) in distal sciatic nerve stumps of rats at the indicated times (14 and 28 days) and in the normal 
sciatic nerve. S100 was used as an SC-specific marker. Spp1 is colocalized in the plasma membrane of S100-positive Schwann cells (scale bar 50 μm). 
e Immunofluorescence staining of S100 (green) and Spp1 (red) (and their overlay) in cultured Schwann cells (scale bar 50 μm). Each experiment was 
repeated three times
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on a DMR fluorescence microscope (Leica Microsystems, 
Bensheim, Germany). The cell proliferation assays were 
performed three times using triplicate wells.
Cell migration assay
Transwell chambers (6.5 mm) with 8-µm pores were used 
to examine SC migration as described previously [21]. 
SCs (106 cells/mL) resuspended in 100 µL of DMEM were 
transferred to the top chamber and allowed to migrate in 
5% CO2 into the lower chamber before the addition of 
600 µL complete medium. Cells adhering to the bottom 
surface of each membrane were stained with 0.1% crystal 
violet, imaged, and counted using a DMR inverted micro-
scope (Leica Microsystems, Bensheim, Germany). The 
cell migration assays were conducted three times using 
triplicate wells.
Immunohistochemistry
The distal sciatic nerve samples were fixed with 4% para-
formaldehyde and dehydrated in 30% sucrose solution. 
Sections were cut using a cryostat to a thickness of 12 µm 
and mounted onto slides. The sections were rinsed in 
PBS, permeabilized in 0.3% Triton X-100, 5% goat serum, 
and 1% BSA in PBS, and then stained. The sections were 
incubated with mouse monoclonal anti-S100 (1:400, 
Sigma) and Spp1 (1:50, Santa Cruz) antibodies at 4 °C for 
12  h, and then incubated with goat anti-mouse or goat 
anti-rabbit IgG Cy3 (1:400, Sigma) and IgG Alexa Fluor 
488 (1:400, Invitrogen) at room temperature for 2 h. The 
sections were counterstained with Hoechst 33342 for 
5  min. All samples were observed under a fluorescence 
microscope. Images were acquired using a laser micro-
scope (FV10i-oil, Tokyo, Japan).
In vivo assay
The sciatic nerve of adult male Sprague–Dawley rats 
was exposed through an incision on the left hind limb 
and cut to create a 1-cm gap. A silicone tube (i.d., 
1.0 mm) was implanted to bridge the nerve gap. The 
rats were randomly divided into two groups (n  =  3 
each): Spp1 siRNA injected into the tube after the 
nerve gap bridge for the experimental group, and a 
control group. At 7 and 14 days after surgery, the rats 
were killed, and the silicone tubes together with the 
regenerated nerves were collected. Real-time PCR and 
Western blot analyses were conducted. The nerve sam-
ples (7 and 14 days) were analyzed in three independ-
ent experiments.
Statistical analysis
Statistical analyses were performed using SPSS 15.0 for 
windows (SPSS, Chicago, IL, USA). Group differences 
were analyzed by one-way analysis of variance and Schef-
fé’s post hoc test when appropriate. Student’s t test was 
used for comparisons between two groups. Values of p 
less than 0.05 were considered statistically significant. All 
data are expressed as mean ± SD.
Fig. 2 Cytokine expression in SC Spp1 knockdown and overexpres-
sion. a Spp1 siRNA-1, 2, 3 transfection efficiency assay (*p < 0.05). b 
Real-time qPCR analysis of bax, bcl2, nf2, NT3, and PKCα mRNA expres-
sion levels after Spp1 siRNA-858 transfection of SCs for 2 days. GAPDH 
was used to normalize values to the negative control (*p < 0.05). The 
average of three independent experiments is shown as mean ± SEM. 
c Real-time qPCR analysis of bax, bcl2, nf2, NT3, and PKCα mRNA 
expression levels after pcDNA3.1-Spp1 plasmid transfection of SCs 
for 2 days, using GAPDH to normalize data to the negative control 
(*p < 0.05). The average of three independent experiments is shown 
as mean ± SEM
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Results
Spp1 is expressed in injured sciatic nerves and in Schwann 
cells
We used real-time qPCR and Western blot analyses to 
determine the expression of Spp1 0, 6, 12, and 24  h as 
well as 1 and 2 weeks after sciatic nerve injury. The real-
time qPRC results indicated that Spp1 mRNA expres-
sion was increased from 6 to 24 h after injury and then 
decreased. Spp1 mRNA level was significantly higher at 
6 h after injury. Our western blot assay results indicated 
that Spp1 protein expression was increased from 6  h 
to 2  weeks. Spp1 protein level was significant higher at 
1 w after injury. GAPDH levels were used as a control 
(Fig.  1a–c). We used immunohistochemistry to visual-
ize the location of Spp1 and S100 at 0, 14, 28 days after 
sciatic nerve injury and in cultured Schwann cells. The 
Schwann cells were immunostained with anti-S100, 
which is a specific Schwann cell marker. The results of 
our immunostaining assay demonstrated that Spp1 and 
S100 were colocalized in Schwann cells (Fig. 1d), indicat-
ing that Spp1 is expressed in the Schwann cells of the sci-
atic nerve. We also examined the expression of Spp1 in 
cultured Schwann cells. The data indicated that Spp1 was 
also present in cultured Schwann cells (p < 0.05, vs. day 0; 
Fig. 1e). All data were analyzed using one-way analysis of 
variance and Scheffé’s post hoc tests (*p < 0.05).
Spp1 knockdown and overexpression in transfected SCs 
alters mRNA expression levels
We synthesized three specific Spp1 siRNAs—siRNA-
1, siRNA-2 and siRNA-3—and all three were found to 
reduce Spp1 mRNA expression levels. The interference 
transfection efficiencies of two of the siRNA fragments 
were at least 80% (Fig.  2a); thus, we selected the most 
efficient one, siRNA-3 (siRNA-858), for the following 
experiment. To investigate the potential functions of 
Fig. 3 Expression of c-Fos, PKCα and p-ERK/ERK protein levels in SC Spp1 knockdown and overexpression. a Western blot analysis of c-Fos, PKCα 
and p-ERK/ERK expression after Spp1 siRNA-858 transfection of SCs for 2 days, using GAPDH to normalize data to negative controls. The average of 
three independent experiments is shown as mean ± SEM. b–d Relative protein expression levels of c-Fos, PKCα, and p-ERK/ERK as determined by 
Western blot analysis. e Western blot analysis of c-Fos, PKCα, and p-ERK/ERK expression after pcDNA3.1-Spp1 plasmid transfection of SCs for 2 days, 
using GAPDH to normalize data to negative controls. The average of three independent experiments is shown as mean ± SEM. f–h Relative protein 
expression levels of c-Fos, PKCα, and p-ERK/ERK as determined by Western blot analysis
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Spp1 in SCs, including on cytokine release, we analyzed 
the mRNA levels of the pro-apoptotic factors B-cell lym-
phoma 2 (Bcl2) and Bcl-2-associated X protein (Bax) as 
well as neurofibromin 2 (Nf2), neurotrophin 3 (NT3) 
and PKCα after Spp1 knockdown and overexpression in 
transfected SCs. Our real-time qPCR results showed that 
bax, bcl2, Nf2 and PKCα mRNA expression levels were 
downregulated in SCs with Spp1 knocked down and 
upregulated by Spp1 overexpression in SCs. By contrast, 
the expression of NT3 mRNA was upregulated by Spp1 
knockdown and downregulated by Spp1 overexpression 
in SCs (Fig. 2b, c) (*p < 0.05). These data indicated that 
the differential expression of Spp1 alters mRNA expres-
sion levels in SCs.
Fig. 4 Spp1 knockdown and overexpression affect SC apoptosis. a, b Silencing Spp1 by transfection with Spp1 siRNA significantly induces apop-
tosis of SCs compared with that in negative controls (NC). c, d Overexpression of Spp1 in SCs by transfection with the pcDNA3.1-Spp1 plasmid 
significantly inhibits SC apoptosis compared with that in NCs. e Relative numbers of SCs with the Spp1 knockdown. f Relative numbers of SCs 
overexpressing Spp1. The average of three independent experiments is shown as mean ± SEM (*p < 0.05)
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Spp1 affects c‑Fos, PKCα, and ERK signaling pathways 
in vitro
As shown above, altered Spp1 expression resulted in 
changes in mRNA expression levels that could affect 
cytokines. We next examined whether Spp1 affected 
signaling pathways in  vitro using cultured SCs. Protein 
expression levels of c-Fos, PKCα and p-ERK/ERK were 
compared with those in negative control SCs using West-
ern blot analysis. We found that protein levels of c-Fos, 
PKCα and p-ERK/ERK were significantly changed after 
transfection of Spp1 siRNA and the pcDNA3.1-Spp1 
plasmid (*p  <  0.05), indicating that c-Fos, PKCα and 
p-ERK/ERK signaling pathways could be activated by 
Spp1 (Fig.  3). Thus, Spp1 may play roles in regulating 
Fig. 5 Spp1 knockdown and overexpression affect SCs proliferation. a, b Silencing of Spp1 by transfection with Spp1 siRNA significantly inhibits 
SC proliferation compared with that in negative controls (NCs). c, d Overexpression of Spp1 by transfection with the pcDNA3.1-Spp1 plasmid 
significantly induces SC proliferation compared with that in NCs. e Relative numbers of SCs with the Spp1 knockdown. f Relative numbers of SCs 
overexpressing Spp1 (scale bar 100 μm). The average of three independent experiments is shown as mean ± SEM (*p < 0.05)
Fig. 6 Spp1 knockdown and overexpression affect SCs migration. a, b Silencing of Spp1 by transfection with Spp1 siRNA in SCs significantly 
induces SC migration compared with that in negative controls (NCs). c, d Overexpression of Spp1 by transfection with the pcDNA3.1-Spp1 plasmid 
significantly inhibits SC migration compared with that in NCs. e Relative numbers of SCs with the Spp1 knockdown. f Relative numbers of SCs 
overexpressing Spp1. The average of three independent experiments is shown as mean ± SEM (*p < 0.05)
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c-Fos, PKCα, and p-ERK/ERK signaling pathways in cul-
tured SCs in vitro.
Spp1 affects SC apoptosis, proliferation, and migration 
in vitro
To determine the function of Spp1 in SCs, primary SCs 
were transfected with Spp1 siRNA, pcDNA3.1-Spp1 plas-
mid, or negative control vector, and the effects of these 
transfections on cell apoptosis, proliferation, and migra-
tion of SCs were examined in vitro. Compared with that 
in negative controls, the apoptosis rate of SCs transfected 
with Spp1 siRNA was increased (1.5-fold) and that of SCs 
transfected with pcDNA3.1-Spp1 was decreased (2.0-
fold; Fig.  4) (*p  <  0.05), suggesting that silencing Spp1 
induced SC apoptosis, whereas enhancing Spp1 expres-
sion reduced SC apoptosis. The results of our EdU-based 
proliferation assay indicated that compared with the 
proliferation rate of SCs in negative controls, that of SCs 
transfected with Spp1 siRNA was decreased (1.8-fold), 
whereas that of SCs transfected with the pcDNA3.1-
Spp1 plasmid was increased (1.5-fold; Fig. 5) (*p < 0.05). 
We also found that the migration rate of SCs transfected 
with Spp1 siRNA was increased (1.6-fold), whereas that 
of SCs transfected with the pcDNA3.1-Spp1 plasmid was 
decreased (1.8-fold) as compared with that of the nega-
tive control (Fig.  6) (*p  <  0.05). These results indicated 
that the expression of Spp1 affects SC apoptosis, prolif-
eration, and migration in vitro.
Altered Spp1 expression affects sciatic nerve injury was 
been assed in vivo
To determine the effect of Spp1 on WD after rat sciatic 
nerve injury in vivo, we examined the functions of Spp1 
on rat sciatic nerve repair and regeneration 1 and 2 weeks 
after injury. After exposing the injured sciatic nerves to 
either Spp1 siRNA or the negative control vector for 1 or 
2 weeks, we conducted real-time qPCR and Western blot 
analyses. Our results indicated that altered Spp1 expres-
sion affected the mRNA and protein expression levels of 
the cytokines Bax, Bcl2, NT3, and early growth response 
2 (EGR2) as well as of PKCα and differentially regulated 
the c-Fos, PKCα and p-ERK/ERK signaling pathways 
(Fig. 7) (*p < 0.05). These results were consistent with the 
functions of Spp1 observed in vitro.
Fig. 7 Altered Spp1 expression affects cytokine expression and c-Fos, PKCα and p-ERK/ERK pathways in vivo. a Real-time qPCR analysis of Spp1, bax, 
bcl2, NT3, PKCα and EGR2 expression levels after exposure of injured rat sciatic nerves to Spp1 siRNA-858 for 1 and 2 weeks. GAPDH levels were used 
as a control (*p < 0.05). The average of three independent experiments is shown as mean ± SEM. b Western blot analysis of Spp1, c-Fos, p-ERK/ERK, 
and PKCα protein expression levels after injured rat sciatic nerves were exposed to Spp1 siRNA-858 for 1 and 2 weeks. GAPDH levels were used as a 
control (*p < 0.05). c–f Relative protein expression levels of Spp1, c-Fos, p-ERK/ERK, and PKCα as determined by Western blot analysis. The average of 
three independent experiments is shown as mean ± SEM (*p < 0.05)
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Discussion
Peripheral nerve injury and repair is a result of reacti-
vated regeneration mechanisms in combination with 
newly activated injury-dependent reactions. Our data 
indicated that gene and protein expression changes after 
sciatic nerve injury appeared to provide separate signals 
that were characterized by a high degree of overlapping 
genes [22–25]. These signals are thought to recruit neu-
trophils and may amplify proinflammatory cytokine 
responses via the phosphatidylinositol 3-kinase/nuclear 
factor-kappa B pathway to activate the processes of nerve 
injury, repair, and regeneration [21, 26–33].
In the present study, we determined the effect of 
Spp1 on nerve repair and rejuvenation after sciatic 
nerve injury in vitro and vivo. Spp1 has been described 
as a component of the inflammatory environment of 
dystrophic and injured tissues [17]. Different cell types 
may differ in their regulatory mechanisms of the Spp1 
gene. Although Spp1 is also important for the migra-
tion of neutrophils in  vitro [34–42], regulation of the 
Spp1 gene is incompletely understood. Our results 
indicated that Spp1 mediates cell activation and 
cytokine production after sciatic nerve injury. In addi-
tion, Spp1 may act as an important anti-apoptotic fac-
tor and may prevent non-programmed cell death in 
inflammatory colitis. Spp1 was previously shown to act 
as a macrophage chemotactic factor and play an impor-
tant role in mast cell migration [17]. Here, we reported 
the functions of Spp1 in the injured sciatic nerve dur-
ing WD. Stimulation of Spp1 expression resulted in 
cytokine expression changes and may regulate c-Fos, 
PKCα and p-ERK/ERK pathways in vitro. Altered Spp1 
expression was also shown to affect SC proliferation, 
migration, and apoptosis. We also verified these data 
in  vivo. Further studies will be necessary to identify 
the key regulatory factors, how they regulate signaling 
pathways in vivo, and their functions during WD after 
peripheral nerve injury.
Conclusions
Spp1 is differentially expressed during WD after rat sci-
atic nerve injury. In vitro and vivo analyses revealed that 
Spp1 is a key regulatory factor that affects nerve degen-
eration and regeneration through c-Fos, PKCα, and 
p-ERK/ERK pathways after rat sciatic nerve injury. We 
concluded that Spp1 plays important roles in peripheral 
nerve injury, repair, and regeneration.
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